Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience.

Patel, Dilan A; Johanns, Tanner M; Trinkaus, Kathryn; Bartlett, Nancy L; Wagner-Johnston, Nina; Cashen, Amanda F

Patel, Dilan A; Johanns, Tanner M; Trinkaus, Kathryn; Bartlett, Nancy L; Wagner-Johnston, Nina; Cashen, Amanda F.

Afiliação

Patel DA; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO.
Johanns TM; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO.
Trinkaus K; Biostatistics Shared Resource, Siteman Cancer Center, St. Louis, MO.
Bartlett NL; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO.
Wagner-Johnston N; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Cashen AF; Division of Medical Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO. Electronic address: acashen@wustl.edu.

Clin Lymphoma Myeloma Leuk ; 19(12): 806-811, 2019 12.

Article em En | MEDLINE | ID: mdl-31648954

Assuntos

Antineoplásicos Imunológicos/administração & dosagem; Linfoma Difuso de Grandes Células B/tratamento farmacológico; Linfoma Difuso de Grandes Células B/mortalidade; Terapia de Alvo Molecular; Rituximab/administração & dosagem; Biomarcadores Tumorais; Vias de Administração de Medicamentos; Feminino; Humanos; Linfoma Difuso de Grandes Células B/diagnóstico; Linfoma Difuso de Grandes Células B/etiologia; Masculino; Terapia de Alvo Molecular/métodos; Estadiamento de Neoplasias; Prognóstico; Modelos de Riscos Proporcionais; Resultado do Tratamento

Palavras-chave

Complement; Diffuse large B-cell lymphoma; Immunochemotherapy; Infusion reaction; Rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Terapia de Alvo Molecular / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google